Le Bonheur and UTHSC researcher receives American Lung Association Innovation Award

Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center announced today that Amali Samarasinghe, PhD, was awarded the Charles and Amelia Gould Innovation award amounting to $75 thousand over two years through the American Lung Association’s Awards and Grants Program. The Lung Association has committed $11.55 million through 98 awards to fund…

JNIS™: cuts in Medicare payments jeopardize patient access to care

FAIRFAX, Va.– The final 2021 Medicare Physician Fee Schedule (MPFS) issued this week by the Centers for Medicare & Medicaid Services (CMS) will result in reimbursement cuts in the range of 10% for neurointerventional procedures, according to a detailed analysis published last week in the Journal of NeuroInterventional Surgery™, the leading international peer-reviewed journal for…

New review confirms disproportionate impact of COVID-19 on Black, Hispanic populations

Black and Hispanic populations are disproportionately affected by COVID-19, according to a systematic review published this week. The disparities were likely related to minority populations being at higher risk of exposure to the coronavirus as opposed to underlying health conditions or other factors, according to the review led by researchers at Oregon Health & Science…

NCCU project examines path from research discovery to better patient care

NCCU project examines path from research discovery to better patient care DURHAM, N.C. – North Carolina Central University’s Julius L. Chambers Biomedical/Biotechnology Research Institute is launching a pilot program to examine how research-based health findings can be used more effectively to address health disparities and improve patient care in minority populations. The program, funded in…

Medicine-carriers made from human cells can cure lung infections

SPOKANE, Wash. – Scientists used human white blood cell membranes to carry two drugs, an antibiotic and an anti-inflammatory, directly to infected lungs in mice. The nano-sized drug delivery method developed at Washington State University successfully treated both the bacterial growth and inflammation in the mice’s lungs. The study, recently published in Communications Biology, shows…